Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 115687
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115687
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115687
Table 2 Comparison of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and carcinoembryonic antigen, mean ± SD
| Indicator | Survival group (n = 77) | Death group (n = 43) | t/χ2 | P value |
| NLR (%) | 2.98 ± 0.57 | 4.83 ± 1.25 | 11.11 | < 0.0001 |
| PLR (%) | 136.26 ± 2.54 | 162.33 ± 27.67 | 8.232 | < 0.0001 |
| CEA (ng/mL) | 12.19 ± 4.51 | 20.17 ± 5.29 | 8.722 | < 0.0001 |
- Citation: Wang T, Liu C, Jiang J. Clinical prediction of carcinoembryonic antigen combined with neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for postoperative survival in colorectal cancer. World J Gastrointest Oncol 2026; 18(4): 115687
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/115687.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.115687